.On the heels of an FDA denial for its primary rivalrous Novo Nordisk, Eli Lilly is actually making ...
.Just a handful of months after application the first client in a phase 2 test for freshly detected ...
.Eli Lilly's look for obesity aim ats has led it to the darker genome. The Big Pharma has produced a...
.Arsenal Biosciences is moving on up. The tissue treatment company has added $325 million in ammunit...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...
.Aelis Farma's chances of protecting a quick, good choice on a $100 million choice repayment have ac...
.ProKidney has actually stopped some of a set of stage 3 trials for its tissue therapy for renal dis...
.Vaxcyte introduced what experts named "impressive" stage 1/2 data for its own 31-valent pneumococca...
.Recursion has stumbled with an early test of its own tech-enabled method to drug revelation, report...
.Contact it a scenario of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning ...